Wockhardt share news and announcements
NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap
Last close ₹1,801.70down ₹53.80 (2.90%)BSE ₹1,801.25
Share price at the NSE close on 23 Oct 2026. Previous close ₹1,855.50.
52-week range of traded prices to 23 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹29,276 Cr311th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- 71.6
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 5.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 8.8%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 7.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.40
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 8,79,19043.6% delivered
Wockhardt share news and announcements
1,008 announcements, routine notices left out, newest first. Page 16 of 21.
Apr 2013
26 Apr · Updates
Company had issued OCCRPS - 2, which were optionally convertible on or after July 04, 2016 and if not converted were to be redeemed on December 31, 2018. Pursuant to the modification in the terms of the said OCCRPS- 2, the Company has redeemed 116,539,748 OCCRPS -2.
Mar 2013
7 Mar · Disclosure
Compensation Committee of the Board has approved the Grant of 8,500 stock options @ Rs. 5/- per option to Independent Directors of the Company, convertible into 8,500 equity shares of Rs. 5/- each under Wockhardt Employees' Stock Options Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999.
Feb 2013
1 Feb · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2012.
Jan 2013
25 Jan · Business
25,300 equity shares of face value of Rs.5/- each of the company are allotted pursuant to exercise of employee stock options under ESOP Scheme - 2011 of the Company.
Dec 2012
26 Dec · Business
122,200 equity shares of face value of Rs.5/- each of the Company were allotted pursuant to exercise of employee stock options
Nov 2012
30 Nov · Updates
Company had issued 208,555,274 OCCRPS-1, which were optionally convertible on or after October 25, 2015 and if not converted were to be redeemed on December 31, 2018. Pursuant to the modification in the terms of the said OCCRPS-1, the Company has redeemed the entire 208,555,274 OCCRPS-1 on November 27, 2012.2 Nov · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2012.
Sep 2012
24 Sep · Updates
Winding-up petition filed by the Trustees to the Foreign Currency Convertible Bonds before the Hon'ble Bombay High Court has been withdrawn.
Aug 2012
6 Aug · Meeting
Annual General Meeting of the Company will be held on September 13, 2012. Further, the Register of Members and Share Transfer Books of the Company shall remain closed from September 05, 2012 to September 13, 2012(both days inclusive) for the purpose of Annual General Meeting of the Company and declaration of Preference dividend.
Jul 2012
27 Jul · Updates
Company had entered into an agreement with Danone for divestment of its Nutrition Business. The Company on July 26, 2012 has closed the said transaction for a consideration of Rs.1,280 crores, including its wholly owned subsidiary.23 Jul · Board meeting
Inter alia , to consider and approve the unaudited financial results of the company for the quarter ended June 30, 2012.
Jun 2012
27 Jun · Disclosure
Compensation Committee of the Board, has approved the Grant of 3,50,000 Stock Options @ Rs. 5/- per option convertible into 3,50,000 equity shares of Rs. 5/- each under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock purchase Scheme) Guidelines, 1999.25 Jun · Demise of Director
Dr. Abid Hussain, Non-Executive and Independent Director of the Company passed away on June 21, 2012. The Board places on record its appreciation for the valuable guidance and contribution to the board made by him during his tenure as a Director of the Company and extends its deepest condolence to his family.
May 2012
22 May · Dividend
Board of Directors of the Company at its meeting held May 22, 2012 has recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs.21,75,171/- and dividend distribution tax of Rs. 3,52,867/-, on cumulative basis, on 107,61,98,988 Non- Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 44,65,49,949 Optionally Convertible Cumulative Redeemable Preference Share of Rs. 5/- each out of the net profits of the Company as per the provisions of section 205 of the Companies Act, 1956. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.10 May · Board meeting
Inter alia, to consider and approve the audited financial results of the Company for the quarter and year ended March 31, 2012.2 May · Results
Company will submit Audited Financial Results for the Financial Year ended March 31, 2012 on or before May 30, 2012 and hence the unaudited financial results for the last quarter ended March 31, 2012 will not be submitted to the Exchange.
Apr 2012
Feb 2012
2 Feb · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and nine months ended December 31, 2011.
Jan 2012
Nov 2011
18 Nov · Board meeting
Compensation Committee of the Board at its meeting held on November 12, 2011, inter alia, has approved the Grant of 1,540,000 Stock Options convertible into 1,540,000 equity shares of Rs. 5/- each (60,000 options @ Rs. 397/- per option; 60,000 options @ Rs. 365/- per option; 1,420,000 options @ Rs. 5/- per option) under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, to the selected employees of the Company and its subsidiaries.12 Nov · Disclosure
Compensation Committee of the Board at its meeting held on November 12, 2011 has approved the Grant of 1,540,000 Stock Options convertible into 1,540,000 equity shares of Rs. 5/- each (60,000 options @ Rs.397/- per option; 60,000 options @ Rs.365/- per option; 1,420,000 options @ Rs. 5/- per option) under Wockhardt Stock Option Scheme - 2011, in accordance with the provisions of Securities and Exchange Board of India (Employees Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999, to the selected employees of the Company and its subsidiaries.3 Nov · Board meeting
Inter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2011.
Sep 2011
Aug 2011
10 Aug · Meeting
Annual General Meeting of the company will be held on September 12, 2011.10 Aug · Meeting
Share Transfer Books and Register of Members of the Company will remain closed from September 05, 2011 to September 12, 2011 (both days inclusive) for the purpose of Annual General Meeting.9 Aug · Board meeting
Board of Directors of the Company at its meeting held on August 09, 2011, inter alia, considered and approved Employee Stock option Scheme - 2011 (Wockhardt ESOS - 2011) and issuance of 25,00,000 stock options to the permanent bonafide employees and directors of the Company and its Holding and Subsidiary Company under Wockhardt ESOS - 2011. Each option covers one equity share and thus aggregate number of 25,00,000 equity shares of face value of Rs. 5/- each are covered under Wockhardt ESOS - 2011. The said issuance of ESOP will be subject to the approval of the members of the Company.